| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $63,095.73 | $63,095.73 | $70,794.58 | |
United
| Professional | $707.95 | $1,023.29 | $1,122.02 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection, and post administration monitoring in the home or residence. This includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $63,095.73 | $63,095.73 | $70,794.58 | |
United
| Professional | $707.95 | $1,023.29 | $1,122.02 |